← Evidence map

ArticlePharmaceutics2026

A Multi-Target Nitrogen-Fused Azole Drug Platform Derived from a Pyrazoline-Thiadiazole Moiety: In Vivo Antimicrobial Validation and Comprehensive Anticancer Investigation Supported by Computational Studies.

Hagar S El-Hema et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 42076076